Beam Therapeutics, Inc. (BEAM)
32.05
-3.36
(-9.49%)
USD |
NASDAQ |
Jan 15, 16:00
32.31
+0.26
(+0.81%)
After-Hours: 20:00
Beam Therapeutics SG&A Expense (TTM): 110.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.17M |
| Twist Bioscience Corp. | 246.98M |
| ANI Pharmaceuticals, Inc. | 304.67M |
| Pacific Biosciences of California, Inc. | 149.08M |
| Regeneron Pharmaceuticals, Inc. | 2.717B |